Back
Theravance Biopharma Stock Price Chart
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
39
TBPH
Theravance Biopharma
Last Price:
$11.61
Seasonality Move:
-3.18%
7 Day Trial
ALL ACCESS PASS
$
7
-
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and TBPH is experiencing buying pressure, which is a positive indicator for future bullish movement.
Theravance Biopharma Price Chart Indicators
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 11.44 | Buy |
| 20-day SMA: | 11.06 | Buy |
| 50-day SMA: | 10.37 | Buy |
| 200-day SMA: | 9.45 | Buy |
| 8-day EMA: | 9.52 | Buy |
| 20-day EMA: | 5.78 | Buy |
| 50-day EMA: | 2.8 | Buy |
| 200-day EMA: | 0.77 | Buy |
Theravance Biopharma Technical Analysis Indicators
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 3.14 | Buy |
| Relative Strength Index (14 RSI): | 65.67 | Buy |
| Chaikin Money Flow: | 145121 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (10.63 - 11.35) | Buy |
| Bollinger Bands (100): | (8.89 - 10.71) | Buy |
Theravance Biopharma Technical Analysis
| Jul 2 | Jul 3 | Jul 7 | Jul 8 | Jul 9 | Jul 10 | Jul 11 | Jul 14 | Jul 15 | Jul 16 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Jul | ||||||||||
| 02 | 03 | 07 | 08 | 09 | 10 | 11 | 14 | 15 | 16 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Technical Analysis for Theravance Biopharma Stock
Is Theravance Biopharma Stock a Buy?
-
Theravance Biopharma share price is 11.65 while TBPH 8-day simple moving average is 11.44, which is a Buy signal.
-
The stock price of TBPH is 11.65 while Theravance Biopharma 20-day SMA is 11.06, which makes it a Buy.
-
Theravance Biopharma 50-day simple moving average is 10.37 while TBPH share price is 11.65, making it a Buy technically.
-
TBPH stock price is 11.65 and Theravance Biopharma 200-day simple moving average is 9.45, creating a Buy signal.
TBPH Technical Analysis vs Fundamental Analysis
Sell
39
Theravance Biopharma (TBPH)
is a Sell
Is Theravance Biopharma a Buy or a Sell?
-
Theravance Biopharma stock is rated a SellThe current Theravance Biopharma [TBPH] share price is $11.65. The Score for TBPH is 39, which is 22% below its historic median score of 50, and infers higher risk than normal.
Theravance Biopharma Stock Info
Market Cap:
582.5M
Price in USD:
11.65
Share Volume:
199.5K
Theravance Biopharma 52-Week Range
52-Week High:
11.82
52-Week Low:
7.44
Sell
39
Theravance Biopharma (TBPH)
is a Sell
Theravance Biopharma Share Price Forecast
-
What is the Theravance Biopharma stock price today?The Theravance Biopharma stock price is 11.65 USD today.
-
Will TBPH stock go up or go down?Theravance Biopharma> share price is forecast to RISE/FALL based on technical indicators
-
Is Theravance Biopharma overvalued?According to simple moving average, exponential moving average, oscillators, and other technical indicators, Theravance Biopharma is overvalued.
Is Theravance Biopharma Stock a Buy?
-
Theravance Biopharma share price is 11.65 while TBPH 8-day exponential moving average is 9.52, which is a Buy signal.
-
The stock price of TBPH is 11.65 while Theravance Biopharma 20-day EMA is 5.78, which makes it a Buy.
-
Theravance Biopharma 50-day exponential moving average is 2.80 while TBPH share price is 11.65, making it a Buy technically.
-
TBPH stock price is 11.65 and Theravance Biopharma 200-day simple moving average is 0.77, creating a Buy signal.
Fundamental Analysis of Theravance Biopharma
Is Theravance Biopharma a good investment?
-
Analysts estimate an earnings increase this quarter of $0.02 per share, a decrease next quarter of $0.04 per share, an increase this year of $0.50 per share, and a decrease next year of $0.37 per share.
Technical Analysis of Theravance Biopharma
Should I short Theravance Biopharma stock?
-
TBPH Moving Average Covergence Divergence (MACD) indicator is 3.14, suggesting Theravance Biopharma is a Buy
-
Theravance Biopharma Relative Strength Index (RSI) is 65.67, which suggest Theravance Biopharma is overbought
-
The Bollinger Bands (25) for Theravance Biopharma is (10.63 - 11.35), which suggest Theravance Biopharma is a Buy
-
The Bollinger Bands (100) for Theravance Biopharma is (8.89 - 10.71), which suggest Theravance Biopharma is a Buy
* Theravance Biopharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.